PHIN-1314

N/A

Report date: 2023/04/25 16:18:50
NMEFirst In Class

Base Information

Drug NamePHIN-1314
Drug Alias NamePHIN-1314
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursInflammationFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmaIN Corp
China Registration ClassN/A

Develop Information

Active CompaniesPharmaIN Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursInflammationFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A